Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Brain Tumor Imaging
This book describes the basics, the challenges and the limitations of state of the art brain tumor imaging and examines in detail its impact on diagnosis and treatment monitoring. It opens with an introduction to the clinically relevant physical principles of brain imaging. Since MR methodology plays a crucial role in brain imaging, the fundamental aspects of MR spectroscopy, MR perfusion and diffusion-weighted MR methods are described, focusing on the specific demands of brain tumor imaging. The potential and the limits of new imaging methodology are carefully addressed and compared to conventional MR imaging. In the main part of the book, the most important imaging criteria for the differential diagnosis of solid and necrotic brain tumors are delineated and illustrated in examples. A closing section is devoted to the use of MR methods for the monitoring of brain tumor therapy. The book is intended for radiologists, neurologists, neurosurgeons, oncologists and other scientists in the biomedical field with an interest in neuro-oncology.
Brain Tumor Immunotherapy
An authoritative panel of researchers and clinicians critically reviews the entire field to provide a comprehensive guide to modern brain tumor immunotherapy and thereby enhance future research in this area. The contributors detail many of the key laboratory experiments and clinical protocols that are currently being investigated, integrate the available information from previous and ongoing research, and help define the current status of the field. Topics range from adoptive cellular and antibody-mediated immunotherapy of brain tumors to tumor vaccines and related strategies, and include many vanguard experimental strategies and immunological techniques for studying brain tumor immunotherapy. Cutting-edge and comprehensive, Brain Tumor Immunotherapy brings together all the important recent advances in our understanding of central nervous system tumor immunology and illustrates in powerful detail the many new applications now harnessing the immune response for brain tumor therapeutics.
Brain Mapping: The Disorders
Brain Mapping: The Disorders is the first comprehensive text to describe the uses of the latest brain mapping technologies in the evaluation of patients with neurological, neurosurgical and psychiatric disorders. With contributions from the leading figures in the field, this heavily illustrated text is organized by disorders of brain systems, with specific examples of how one should use current neuroimaging techniques to evaluate patients with specific cerebral disorders. Comprehensive in scope, the text discusses patient evaluations using the wide range of modern magnetic resonance imaging techniques, positron emission tomography, single photon emission computed tomography, optical intrinsi...
PET Imaging of Brain Tumors, An Issue of PET Clinics
This issue discusses the clinical application of PET Imaging in assessing brain tumors, Including what a neuro-oncologist’s expectations should be. One article discusses how PET can help in developing reliable response evaluation criteria in brain tumors; another reviews modern tracers for brain tumors. The evolving role of PET-MRI in brain tumors is examined. Parametric mapping of multiple PET tracers with MRI response evaluation is reviewed. Another article discusses the role of early and delayed PET imaging and novel quantitative techniques in hybrid imaging for brain tumors. The perspective of pediatric imaging is also given.
Therapeutic Kinase Inhibitors
Cancer drug development is currently undergoing a profound shift. Drugs targeting fundamental cellular processes such DNA-replication and microtubule function, often referred to as “chemotherapy” and still the backbone of most cancer treatment regimens, are increasingly being complemented by or replaced with kinase inhibitors. This new class of drugs targets enzymes which provide growth and survival signals to cancer cells by transferring phosphate groups from Adenosine-5'-triphosphate (ATP) to other proteins, lipids, nucleotides, and carbohydrates. This book summarizes the current state of kinase inhibitor therapy for cancer. Successful drug development relies on the expertise and dedication of many experts. To reflect this team approach to finding new kinase inhibitors and defining their optimal use for cancer treatment, the editors invited experts in academia and pharmaceutical industry to share their insights into various aspects of this process, ranging from the first chemical screens, to preclinical testing and disease-focused clinical drug development. The editors and authors hope these lessons will be instructive for the novice as well as the expert.
Predictive Intelligence in Medicine
This book constitutes the proceedings of the 5th International Workshop on Predictive Intelligence in Medicine, PRIME 2022, held in conjunction with MICCAI 2022 as a hybrid event in Singapore, in September 2022. The 19 papers presented in this volume were carefully reviewed and selected for inclusion in this book. The contributions describe new cutting-edge predictive models and methods that solve challenging problems in the medical field for a high-precision predictive medicine.
Oncology
None
Celebrity Death Certificates 3
Literally the last word for Hollywood trivia buffs, a celebrity death certificate is also strangely compelling. Its matter-of-fact reportage makes the famous ordinary, illuminating previously well-lit profiles with the unfiltered light of the everyday. A death certificate may also reveal information that stars concealed, such as actual birthdates. In California, death certificates are a matter of public record--a real mine of information. This follow-up to M.F. Steen's previous two collections (2003 and 2005) reproduces in full 226 death certificates. Brief biographical notes are included, listing birth and professional name as well as notable film, television and entertainment credits.
Cancer Research
None
